In an article in GFO 195, we said that “the calculation of committed assets in the forecast includes a provision of $171 million to fund the Affordable Medicines Facility–malaria (AMFm) up to the end of 2013.” This is incorrect. The $171 million for the AMFm is not included in the forecast. The Board paper in which the forecast is discussed says that donor contributions…